Reliv' International, Inc. develops, manufactures, and markets nutritional supplements that address basic nutrition, wellness needs, weight management, and sports nutrition. Its nutritional supplements primarily include Reliv Classic and Reliv NOW, which are basic nutritional supplements containing a balanced blend of vitamins, minerals, proteins, and herbs; Innergize!, an isotonic sports supplement in two flavors; FibRestore, a high-fiber and antioxidant supplement; and LunaRich X, a soy concentrate with elevated levels of lunasin in capsule form. The company markets and sells its products through a network of distributors in the United States, Australia, Austria, Canada, France, Germany, Indonesia, Ireland, Malaysia, Mexico, the Netherlands, New Zealand, the Philippines, Singapore, and the United Kingdom. Reliv' International, Inc. was founded in 1984 and is headquartered in Chesterfield, Missouri.
Industry, Sector and Symbol
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorConsumer Staples
Phone636-537-9715
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$36.12 million
Profitability
Miscellaneous
Employees156
Next Earnings Date11/8/2019 (Estimated)
OptionableNot Optionable
Reliv International (NASDAQ:RELV) Frequently Asked Questions
What is Reliv International's stock symbol?
Reliv International trades on the NASDAQ under the ticker symbol "RELV."
How were Reliv International's earnings last quarter?
Reliv International, Inc (NASDAQ:RELV) announced its quarterly earnings data on Friday, August, 9th. The company reported ($0.22) EPS for the quarter. The company had revenue of $8.26 million for the quarter. Reliv International had a negative net margin of 1.27% and a negative return on equity of 3.75%. View Reliv International's Earnings History.
When is Reliv International's next earnings date?
Has Reliv International been receiving favorable news coverage?
News articles about RELV stock have been trending somewhat positive on Wednesday, InfoTrie Sentiment reports. The research group identifies positive and negative news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Reliv International earned a media sentiment score of 2.0 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the near term. View News Stories for Reliv International.
Are investors shorting Reliv International?
Reliv International saw a decline in short interest in September. As of September 30th, there was short interest totalling 10,600 shares, a decline of 9.4% from the August 30th total of 11,700 shares. Based on an average trading volume of 3,200 shares, the days-to-cover ratio is currently 3.3 days. Approximately 0.9% of the company's stock are sold short. View Reliv International's Current Options Chain.
Who are some of Reliv International's key competitors?
Some companies that are related to Reliv International include Clearside Biomedical (CLSD), Addex Therapeutics (ADDXF), China SXT Pharmaceuticals (SXTC), Fibrocell Science (FCSC), Aptevo Therapeutics (APVO), Zafgen (ZFGN), Leap Therapeutics (LPTX), Akari Therapeutics (AKTX), OncoSec Medical (ONCS), Alimera Sciences (ALIM), Provectus Biopharmaceuticals (PVCT), ContraFect (CFRX), Intec Pharma (NTEC), Ceapro (CRPOF) and Acerus Pharmaceuticals (TRLPF).
What other stocks do shareholders of Reliv International own?
Who are Reliv International's key executives?
Reliv International's management team includes the folowing people:
- Mr. Robert L. Montgomery, Co-Founder & Chairman (Age 77)
- Dr. Carl W. Hastings, Vice Chairman, Chief Scientific Officer & Member of the Scientific Advisory Board (Age 77)
- Mr. Thomas W. Pinnock III, Pres of Sales & Marketing (Age 68)
- Mr. Ryan A. Montgomery, CEO, Pres & Director (Age 45)
- Mr. Steven D. Albright CPA, Sr. VP & CFO (Age 57)
How do I buy shares of Reliv International?
Shares of RELV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Reliv International's stock price today?
One share of RELV stock can currently be purchased for approximately $4.40.
How big of a company is Reliv International?
What is Reliv International's official website?
How can I contact Reliv International?
Reliv International's mailing address is 136 CHESTERFIELD INDUSTRIAL BLVD, CHESTERFIELD MO, 63005. The company can be reached via phone at 636-537-9715 or via email at [email protected]
MarketBeat Community Rating for Reliv International (NASDAQ RELV)
MarketBeat's community ratings are surveys of what our community members think about Reliv International and other stocks. Vote "Outperform" if you believe RELV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RELV will underperform the S&P 500 over the long term. You may vote once every thirty days.
